Skip to main content

BLUE BIOFUELS, INC.

corporate_fare Company Profile

BLUE BIOFUELS, INC.

BIOF·OTC·Industrial Applications And Services·CIK 0001549145

Blue Biofuels, Inc. is a technology company focused on emerging technologies in renewable energy, biofuels, and lignin since December 2013. The company's core offering is its Cellulose-to-Sugar (CTS) process, a continuous mechanical/chemical method for breaking down cellulosic material into biofuels. This process can utilize various cellulosic materials, including grasses and agricultural waste, and allows for precise control to optimize reaction parameters and efficiency. The initial CTS reactor technology was invented by CEO Ben Slager in early 2018, leading to a process patent application. This patent (U.S. Patent No. 10,994,255) was granted in the United States in 2021 and subsequently in Japan, Australia, Russia, and El Salvador. Patent applications are pending in other major jurisdictions, including the European Patent Organization, Brazil, China, and the African Regional Intellectual Property Organization. The company has also secured two additional U.S. patents (U.S. Patent No. 11,484,858B2), with applications filed in the same international jurisdictions, and has 3 other U.S. patent applications currently pending. The company underwent a voluntary Chapter 11 financial restructuring, filing on October 22, 2018, and exiting on September 18, 2019, with the bankruptcy case closing on October 25, 2019.

BLUE BIOFUELS, INC. (OTC:BIOF) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors BIOF SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Blue Biofuels Reports Critically Low Cash, Worsening Losses, and Reiterates Going Concern Warning Amidst Significant Funding Gap
  • Annual Report Highlights Going Concern, $60M Accumulated Deficit, and Critical $90M Financing Need

monitoring Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$2.87M
Diluted EPS
-$0.01
Op. Cash Flow
-$845K
Free Cash Flow
-$913.9K
Operating Income
-$3.72M
Cash & Equivalents
$65.2K
Debt / Equity
0.00×
Shares Outstanding
317.87M sh
Source: 10-K · filed 2026-03-19 · accession 0001493152-26-011555
$0.15
52-week range $0.11 – $0.22
Market cap
$49.43M
Volume
83.8K (0.7× avg)
3-mo avg 120.3K
Price snapshot as of 2026-05-22 01:53 UTC (Market snapshot (OVERNIGHT))

show_chartPrice Chart

Loading chart...

feed BIOF - Latest Insights

BIOF
May 04, 2026, 12:06 PM EDT
Filing Type: 10-Q
Importance Score:
9
BIOF
Mar 19, 2026, 11:17 AM EDT
Filing Type: 10-K
Importance Score:
9